Norman Sussman
Technik-/Wissenschafts-/F&E-Leiter bei DURECT CORPORATION
Vermögen: 1 539 $ am 31.05.2024
Profil
Norman L.
Sussman is the founder of Amphioxus Cell Technologies, Inc. (founded in 1995) where he holds the title of Secretary & Director since 2003.
He was also the founder of Hepatix, Inc. (founded in 1995) where he served as Vice President from 1995 to 2003.
Dr. Sussman's current job is as the Chief Medical Officer at DURECT Corp.
(since 2020).
Dr. Sussman's former jobs include being a Director at Interferon Sciences, Inc. in 2006, a Director at Stem Cell Innovations, Inc., a Director at HepaHope, Inc., and a Director-Telehealth Program & Project ECHO at Baylor St. Luke's Medical Center.
He also served as an Associate Professor-Medicine & Surgery at Baylor College of Medicine.
Dr. Sussman obtained a doctorate degree from the University of the Witwatersrand.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DURECT CORPORATION
0,00% | 26.03.2024 | 900 ( 0,00% ) | 1 539 $ | 31.05.2024 |
Aktive Positionen von Norman Sussman
| Unternehmen | Position | Beginn |
|---|---|---|
| DURECT CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 02.11.2020 |
Amphioxus Cell Technologies, Inc.
 Amphioxus Cell Technologies, Inc. BiotechnologyHealth Technology Amphioxus Cell Technologies, Inc. manufactures biological drug discovery products. It develops human liver based tools from liver biology to drug disposition, viral hepatitis, plasma proteins, and cell culture models. The company was founded by James H. Kelly and Norman L. Sussman in 1995 and is headquartered in Houston, TX. | Gründer | 01.01.1995 |
Ehemalige bekannte Positionen von Norman Sussman
| Unternehmen | Position | Ende |
|---|---|---|
| Interferon Sciences, Inc. | Direktor/Vorstandsmitglied | 16.02.2006 |
| Hepatix, Inc. | Gründer | 01.01.2003 |
| Baylor College of Medicine | Corporate Officer/Principal | - |
Baylor St. Luke's Medical Center
 Baylor St. Luke's Medical Center Miscellaneous Commercial ServicesCommercial Services Baylor St. Luke's Medical Center is an 881-bed academic medical center located in the Texas Medical Center. The hospital also has three community emergency centers offering adult and pediatric care for the greater Houston area. St. Luke's Health provides renowned, high-quality healthcare services throughout the greater Houston area. The private company is based in Houston, TX. It is a joint venture between Baylor College of Medicine and St. Luke's Health. Baylor St. Luke's was the first facility in Texas and the Southwest to be designated a Magnet® hospital for nursing excellence by the American Nurses Credentialing Center, receiving the award five consecutive times. The hospital is home to the Texas Heart® Institute, a cardiovascular research and education institution founded in 1962 by Denton A. Cooley. | Corporate Officer/Principal | - |
HepaHope, Inc.
 HepaHope, Inc. Miscellaneous Commercial ServicesCommercial Services HepaHope, Inc. is a medical technology company, which engaged in researching, designing, patenting, manufacturing, and marketing life-saving medical technologies. The company is focused towards three primary markets, including artificial liver replacement, oncology testing and drug development. The company was founded by Sung-Soo Park in February 1999 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Norman Sussman
| University of the Witwatersrand | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Private Unternehmen | 6 |
|---|---|
| Interferon Sciences, Inc. | Health Technology |
Amphioxus Cell Technologies, Inc.
Amphioxus Cell Technologies, Inc. BiotechnologyHealth Technology Amphioxus Cell Technologies, Inc. manufactures biological drug discovery products. It develops human liver based tools from liver biology to drug disposition, viral hepatitis, plasma proteins, and cell culture models. The company was founded by James H. Kelly and Norman L. Sussman in 1995 and is headquartered in Houston, TX. | Health Technology |
Stem Cell Innovations, Inc.
 Stem Cell Innovations, Inc. Miscellaneous Commercial ServicesCommercial Services Stem Cell Innovations, Inc. conducts pharmacological research based on stem cells. The company was is headquartered in Houston, TX. | Commercial Services |
HepaHope, Inc.
HepaHope, Inc. Miscellaneous Commercial ServicesCommercial Services HepaHope, Inc. is a medical technology company, which engaged in researching, designing, patenting, manufacturing, and marketing life-saving medical technologies. The company is focused towards three primary markets, including artificial liver replacement, oncology testing and drug development. The company was founded by Sung-Soo Park in February 1999 and is headquartered in Irvine, CA. | Commercial Services |
Baylor St. Luke's Medical Center
Baylor St. Luke's Medical Center Miscellaneous Commercial ServicesCommercial Services Baylor St. Luke's Medical Center is an 881-bed academic medical center located in the Texas Medical Center. The hospital also has three community emergency centers offering adult and pediatric care for the greater Houston area. St. Luke's Health provides renowned, high-quality healthcare services throughout the greater Houston area. The private company is based in Houston, TX. It is a joint venture between Baylor College of Medicine and St. Luke's Health. Baylor St. Luke's was the first facility in Texas and the Southwest to be designated a Magnet® hospital for nursing excellence by the American Nurses Credentialing Center, receiving the award five consecutive times. The hospital is home to the Texas Heart® Institute, a cardiovascular research and education institution founded in 1962 by Denton A. Cooley. | Commercial Services |
| Hepatix, Inc. |
